The vaccine from Pfizer was more effective than the Chinese Sinovac

People who have been vaccinated against coronavirus with a BioNTech vaccine produce 10 times more antibodies than those who preferred the Chinese drug Sinovac, the South China Morning Post writes, citing a corresponding study.

According to the study, the level of antibodies produced during Sinovac vaccination is “the same or lower” than that recorded in people who have naturally had COVD-19. This suggests an “alternative strategy” – the use of a booster dose of the vaccine for the most vulnerable groups of the population, including the elderly and people with weak immunity.

“The difference in the concentration of neutralizing (virus) antibodies indicated in our study may mean significant differences in the effectiveness of vaccines,” the newspaper quotes the study.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: